This publication describes PATH’s efforts to examine the use and acceptability of maternal influenza immunization in El Salvador. The qualitative study captures the perspectives of pregnant women, family decision makers, community leaders, public health practitioners, private physicians, and more. The report identifies both successful strategies as well as challenges to vaccine uptake, and offers recommendations for countries considering the introduction of maternal influenza immunization.

Publication date: April 2018

Region: Latin America, Global

This fact sheet describes PATH’s work in maternal immunization—an approach of vaccinating during pregnancy to protect mother and baby. It covers work across vaccine projects targeting respiratory syncytial virus, Group B Streptococcus, influenza, and pertussis—infections that disproportionately threaten mothers and/or newborns.

Publication date: January 2017

Region: Global

This website about PATH’s Ukraine country program provides an overview of the program and its featured projects. See other PATH program websites.

Publication date: 2017

Region: Eastern Europe

Part of series: Program websites

This website about PATH’s Vietnam country program provides an overview of the program and its featured projects. See other PATH program websites.

Publication date: 2017

Region: Asia

Part of series: Program websites

Moving the Needle provides quarterly updates from PATH’s Center for Vaccine Innovation and Access (CVIA) on its vaccine development efforts, as well as related supporting work, such as developing human challenge models, building capacity of developing-country vaccine manufacturers, and evaluating new adjuvants and other novel vaccine technologies. It includes updates on our progress, partnerships, and specific activities. This is one of two newsletters published by CVIA. Immunization Matters covers CVIA’s vaccine uptake and access work.

Publication date: October 2016

Region: Global

This fact sheet describes a project that PATH is implementing in Vietnam with support from the Biomedical Advanced Research and Development Authority within the US Department of Health and Human Services. The project is supporting the enhancement of sustainable influenza vaccine production in Vietnam. PATH is providing technical assistance to various groups in Vietnam to facilitate the production and clinical evaluation of safe and effective influenza vaccines and synergizing activities with work already under way in Vietnam through the World Health Organization.

Publication date: August 2016

Region: Asia

Published from 2007 to 2015, Vaccines for the Future provided quarterly updates on our efforts to accelerate the development of innovative, safe, effective, and affordable vaccines against pneumonia (pneumococcal disease) and diarrheal disease (rotavirus, Shigella, enterotoxigenic Escherichia coli), as well as new vaccines for the global population against influenza, meningitis, polio, and respiratory syncytial virus. It included updates on progress, partnerships, and specific activities related to these projects. This newsletter is no longer being published and has been replaced by two newsletters: Moving the Needle provides updates on our vaccine development work, and Immunization Matters focuses on our vaccine uptake and access work.

Publication date: 2015

Region: Global

Part of series: E-newsletters

This fact sheet highlights PATH's work to advance the development of new vaccines against influenza that are affordable and accessible for the developing world.

Publication date: October 2013

Region: Global

This fact sheet highlights PATH's multifaceted approach to expanding vaccine solutions against influenza that are optimal for the developing world. It describes our efforts to advance the development of promising new influenza vaccines, gain a better understanding of influenza vaccine performance in children in low-resource countries, and help emerging-country manufacturers produce influenza vaccines for pandemic preparedness.

Publication date: October 2013

Region: Global

If a highly virulent pandemic strain were to emerge in today’s interconnected world, influenza has the potential to kill millions of people, especially in developing countries with limited to no resources for pandemic planning, preparedness, and outbreak response. PATH's work in developing thermostable influenza vaccines holds promise for extending product shelf life and easing logistics during introduction and rapid deployment to hard-to-reach populations—markedly improving developing-country preparedness and ability to contain the virus at its point of origin. This fact sheet describes our latest research achievements and next steps in product development.

Publication date: September 2013

Region: Global

This fact sheet describes a phase 3 clinical study that PATH and our partners are conducting in Senegal to evaluate the clinical efficacy of a seasonal, trivalent live attenuated influenza vaccine (LAIV). By providing evidence on how well this type of vaccine works among young children in Senegal, this study will help inform efforts in the scientific community to develop optimal LAIVs for the world’s most vulnerable children, as well as policy decisions for potential future LAIV use in Senegal and other tropical, low-resource countries in Africa.

Publication date: May 2013

Region: Africa

This fact sheet describes a phase 2 influenza vaccine clinical study that PATH and our partners are conducting in Senegal. The study seeks to better understand the performance of seasonal influenza vaccines in a tropical, low-resource region of the country. Overall, the results from this study will provide evidence to support larger research efforts to determine the most feasible and efficient ways of protecting populations in tropical, developing Africa from influenza through the use of vaccines.

Publication date: April 2013

Region: Africa

This fact sheet summarizes PATH's work to curb emerging and epidemic diseases such as HIV/AIDS, tuberculosis, and malaria. Topic areas include advancing technologies to improve prevention, diagnosis, and treatment; strengthening health systems; encouraging healthy behaviors; and mobilizing and supporting our partners.

Publication date: September 2012

Region: Global

Part of series: Areas of focus fact sheets

This issue of Directions in Global Health features PATH’s work to address noncommunicable diseases, such as diabetes and cancer. It also covers efforts to improve health in Kenya, build global and country capacity for influenza control, improve gender equity in China, and integrate health services for better outcomes.

Publication date: December 2011

Region: Global

Part of series: Directions in Global Health

This issue of PATH Today features our work in vaccines, with a focus on how PATH is making "hidden solutions" available, and describes lifesaving changes in South Africa's infant feeding policies. It also includes news from our malaria and meningitis work, an announcement of PATH's new blog, and a profile of PATH donor Lora Kaiser.

Publication date: December 2011

Region: Global

Part of series: PATH Today

This fact sheet describes a phase 4, post-licensure influenza vaccine effectiveness study that PATH and its partners are conducting in Senegal. The study seeks to better understand the extent of the influenza disease burden in tropical Africa, as well as the potential of current seasonal influenza vaccines to reduce influenza-related deaths in the developing world. Ultimately, study data could help public health officials decide how to best use influenza vaccines in Senegal and in similar tropical countries.

Publication date: May 2011

Region: Africa

This edition of PATH Today highlights work to improve children’s health in Nicaragua and Kenya and spotlights PATH's safe water project in Korogocho, a slum near Nairobi, Kenya. It also includes brief updates on the 2009 Breakfast for Global Health, workplace giving, an influenza vaccine study in Africa, and PATH's 2008 annual report.

Publication date: September 2009

Region: Global

Part of series: PATH Today

This issue of Directions in Global Health showcases PATH’s global presence. It highlights work related to influenza in Africa, HIV and AIDS in Eastern Europe,  Japanese encephalitis in Asia, gender-based violence in Latin America and the Caribbean, and diagnostic technologies in North America. The back cover features a map and summary information on PATH’s work around the world.

Publication date: August 2009

Region: Global

Part of series: Directions in Global Health

This document provides the overall framework and specific operational procedures for Ukraine’s health sector response to an influenza pandemic. Its prime objectives are to reduce the health impact of a pandemic and minimize disruption to health and other essential services while maintaining business continuity and reducing the disruption to society.

Publication date: July 2009

Region: Global

Outbreaks of highly pathogenic avian influenza are occurring in domestic fowl in many countries, posing a considerable human public health risk. Based on the latest World Health Organization (WHO) standards and recommendations, this manual provides comprehensive recommendations to help Ukrainian health care workers establish sentinel site surveillance and promptly identify, report, confirm, and classify potential cases of avian influenza in humans. In addition, the document includes guidance on the basic parameters for surveillance data analysis, investigation of trigger cases and outbreaks, improvement of other aspects of an early warning system for humans, and communication with the public and infection-control professionals. The guidelines are most appropriate for the current and the next stages of pandemic preparedness (phases 3 and 4 of the WHO Pandemic Alert Period) and are designed primarily for health care personnel working at rayon and regional sanitary-epidemiological stations.

Publication date: July 2008

Region: Eastern Europe